A systematic review of worldwide epidemiology of psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 31, Issue 2, 2017, Pages 205-212

  Michalek, I M ^a,b   Loring, B ^b   John, S M ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CHINA; EGYPT; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; INCIDENCE; ITALY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SCIENTIFIC LITERATURE; SWEDEN; SYSTEMATIC REVIEW; TAIWAN; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PSORIASIS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84992146581     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13854     Document Type: Review

References (89)

1. Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2010: Results by Cause 1990–2010. IHME, Seattle, 2012.
2. Boehncke W-H, Schön MP. Psoriasis. Lancet 2015; 386: 983–994.
3. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010; 162: 633–636.
4. Vena GA, Altomare G, Ayala F et al. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 2010; 20: 593–598.
5. Russo PAJ, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 2004; 45: 155–159; quiz 160–1.
6. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6: 383–392.
7. Fuji R, Mould JFJ, Tang B et al. Burden of disease in patients with diagnosed psoriasis in Brazil: results from 2011 national health and wellness survey (NHWS). Value Health 2012; 15: A107.
8. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136–139.
9. Augustin M, Reich K, Blome C, Schäfer I, Laass A, Radtke MA. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 2010; 163: 580–585.
10. de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004; 9: 140–147.
11. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366–372.
12. Schmid-Ott G, Künsebeck H-W, Jäger B et al. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 2005; 85: 27–32.
13. Fortune DG, Richards HL, Griffiths CEM, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41(Pt 2): 157–174.
14. World Health Organization. Global report on psoriasis [WWW document] 2016. URL http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf?ua=1 (last accessed: 28 July 2016).
15. Brunasso A, Massone C. Can we really separate palmoplantar pustulosis from psoriasis? J Eur Acad Dermatol Venereol 2010; 24: 619–621.
16. Bell LM, Sedlack R, Beard CM, Perry HO, Michet CJ, Kurland LT. Incidence of psoriasis in Rochester, Minn, 1980–1983. Arch Dermatol 1991; 127: 1184–1187.
17. Donker GA, Foets M, Spreeuwenberg P, van der Werf GT. Management of psoriasis in family practice is now in closer agreement with the guidelines of the Netherlands Society of Family Physicians. Ned Tijdschr Geneeskd 1998; 142: 1379–1383.
18. Huerta C, Rivero E, Rodríguez LAG. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559–1565.
19. Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol 2010; 62: 979–987.
20. Cantarutti A, Donà D, Visentin F et al. Epidemiology of frequently occurring skin diseases in italian children from 2006 to 2012: a retrospective, Population-Based Study. Pediatr Dermatol 2015; 32: 668–678.
21. Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60: 394–401.
22. Ammar-Khodja A, Benkaidali I, Bouadjar B et al. EPIMAG: international cross-sectional epidemiological psoriasis study in the Maghreb. Dermatology 2015; 231: 134–144.
23. Gibbs S. Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol 1996; 35: 633–639.
24. Lima XT, Minnillo R, Spencer JM, Kimball AB. Psoriasis prevalence among the 2009 AAD National Melanoma/Skin Cancer Screening Program participants. J Eur Acad Dermatol Venereol 2013; 27: 680–685.
25. Simpson CR, Anderson WJA, Helms PJ et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002; 32: 37–42.
26. Saraceno R, Mannheimer R, Chimenti S. Regional distribution of psoriasis in Italy. J Eur Acad Dermatol Venereol 2008; 22: 324–329.
27. Cooperative Psoriasis Study Group of China. Distribution of psoriasis in China: a nation-wide screening in 1984. Chin J Dermatol 1986; 19: 253–261.
28. Li M-J, Wang P, Wu W-W et al. An epidemiological survey of psoriasis in 18 cities in Hainan province of China. J Dermatol 2012; 39(Suppl. 1): 243–244.
29. El FN, Khaled A, Kharafi M et al. Epidemiology of psoriasis in Tunisia. J Eur Acad Dermatol Venereol 2007; 21(Suppl 1): 41–41.
30. Johnson MT, Roberts J. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971–1974. Vital Health Stat 11 1978; 212: 1–72.
31. Chang Y-T, Chen T-J, Liu P-C et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009; 89: 262–266.
32. Tsai T-F, Wang T-S, Hung S-T et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 2011; 63: 40–46.
33. Yip SY. The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 1984; 10: 965–968.
34. Ding X, Wang T, Shen Y et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol 2012; 22: 663–667.
35. Wang R, Cao L, Zhou C, Zhang J. Prevalence of 15 skin diseases in adolescents from Liangshan prefecture in Sichuan Province. Chin J Dermatol 2012; 45: 270–272.
36. Lomholt G. A census study on the prevalence of skin diseases in the Faroe Islands. GEC Gad, Copenhagen, 1963.
37. Abdel-Hafez K, Abdel-Aty MA, Hofny ERM. Prevalence of skin diseases in rural areas of Assiut Governorate, Upper Egypt. Int J Dermatol 2003; 42: 887–892.
38. Schaefer I, Rustenbach S, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiologie der Psoriasis in Deutschland – Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung. Gesundheitswesen 2011; 73: 308–313.
39. Augustin M, Radtke M, Glaeske G, Schafer I. Epidemiology, co morbidity and economics of psoriasis in Germany: analysis of health insurance data from 1.3 Mio. persons including 34,000 psoriatics. Exp Dermatol 2010; 19: 224–224.
40. Schlander M, Schwarz O, Viapiano M, Bonauer N. Administrative prevalence of psoriasis in Germany. Value Health 2008; 11: A615–A616.
41. Kubota K, Kamijima Y, Sato T et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open 2015; 5: e006450.
42. Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl (Stockh) 1989; 142: 9–12.
43. Falk ES, Vandbakk O. Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol Suppl (Stockh) 1993; 182: 6–9.
44. Borzęcki A, Dudra-Jastrzębska M, Sajdak-Wojtaluk A. Epidemiologia łuszczycy w rejonie województwa lubelskiego w latach 2005–2009. Dermatol Klin 2012; 14: 149–153.
45. Massa A, Alves R, Amado J et al. Prevalence of cutaneous lesions in Freixo de Espada à Cinta. Acta Médica Port 2000; 13: 247–254.
46. Ferrándiz C, Bordas X, García-Patos V, Puig S, Pujol R, Smandía A. Prevalence of psoriasis in Spain (Epiderma Project: phase I). J Eur Acad Dermatol Venereol 2001; 15: 20–23.
47. Ferrándiz C, Carrascosa JM, Toro M. Prevalence of psoriasis in Spain in the age of biologics. Actas Dermo-Sifiliográficas 2014; 105: 504–509.
48. Perera A, Atukorale DN, Sivayogan S, Ariyaratne VS, Karunaratne LA. Prevalence of skin diseases in suburban Sri Lanka. Ceylon Med J 2000; 45: 123–128.
49. Lofvendahl S, Theander E, Svensson A, Englund M, Turkiewicz A, Petersson I. The prevalence of psoriasis and psoriatic arthritis in Sweden a health care register study. Arthritis Rheum 2009; 60(Suppl. 10): 710.
50. Lofvendahl S, Theander E, Svensson A, Englund M, Turkiewicz A, Petersson I. Prevalence of doctor-diagnosed psoriasis and psoriatic arthritis in southern Sweden. Br J Dermatol 2012; 167: e11.
51. Seminara NM, Abuabara K, Shin DB et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 2011; 164: 602–609.
52. Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the disease. Br J Dermatol 1996; 135: 533–537.
53. Gelfand JM, Neimann AL, Weinstein R, Porter S, Margolis D. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. J Invest Dermatol 2005; 124(4 Suppl S): A48–A48.
54. Kay L, Parry-James J, Walker D. The prevalence and impact of psoriasis and psoriatic arthritis in the primary care population in North East England. Arthritis Rheum 1999; 42: S299–S299.
55. Gillard SE, Finlay AY. Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care. Int J Clin Pract 2005; 59: 1260–1267.
56. Arzensek J, Kansky A, Kavcic C. Epidemiology of psoriasis in Celje area. Acta Derm Venereol 1984; 64: 106–108.
57. Yang Y-C, Cheng Y-W, Lai C-S, Chen W. Prevalence of childhood acne, ephelides, warts, atopic dermatitis, psoriasis, alopecia areata and keloid in Kaohsiung County, Taiwan: a community-based clinical survey. J Eur Acad Dermatol Venereol 2007; 21: 643–649.
58. Chen G-Y, Cheng Y-W, Wang C-Y et al. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: a community-based clinical survey. J Formos Med Assoc Taiwan Yi Zhi 2008; 107: 21–29.
59. Schmitt J, Apfelbacher C. Epidemiology of pediatric psoriasis: a representative German cross-sectional study. Exp Dermatol 2010; 19: 219–219.
60. Yamamah GA, Emam HM, Abdelhamid MF et al. Epidemiologic study of dermatologic disorders among children in South Sinai, Egypt. Int J Dermatol 2012; 51: 1180–1185.
61. El-Khateeb EA, Lotfi RA, Abd EK, Abdel-Aziz KM, El-Shiekh SE. Prevalences of skin diseases among primary schoolchildren in Damietta, Egypt. Int J Dermatol 2014; 53: 609–616.
62. Matusiewicz D, Koerber A, Schadendorf D, Wasem J, Neumann A. Childhood psoriasis–an analysis of German health insurance data. Pediatr Dermatol 2014; 31: 8–13.
63. Augustin M, Radtke MA, Glaeske G et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatol Basel Switz 2015; 231: 35–40.
64. Kampfe S, Augustin M, Schafer I, Glaeske G, Schicktanz C, Radtke M. Prevalence and health care situation of juvenile psoriasis in Germany. Exp Dermatol 2012; 21: e21–e21.
65. Larsson PA, Lidén S. Prevalence of skin diseases among adolescents 12–16 years of age. Acta Derm Venereol 1980; 60: 415–423.
66. Takeshita J, Gelfand JM, Li P et al. Psoriasis in the US medicare population: prevalence, treatment, and factors associated with biologic use. J Invest Dermatol 2015; 135: 2955–2963.
67. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol 2013; 168: 1303–1310.
68. Helmick CG, Lee-Han H, Hirsch SC, Baird TL, Bartlett CL. Prevalence of psoriasis among adults in the US: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys. Am J Prev Med 2014; 47: 37–45.
69. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ 1996; 313: 919–921.
70. Quirk CJ. Skin disease in the Busselton population survey. Med J Aust 1979; 1: 569–570.
71. Plunkett A, Merlin K, Gill D, Zuo Y, Jolley D, Marks R. The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia. Int J Dermatol 1999; 38: 901–908.
72. Kilkenny M, Stathakis V, Jolley D, Marks R. Maryborough skin health survey: prevalence and sources of advice for skin conditions. Australas J Dermatol 1998; 39: 233–237.
73. Barisic-Drusko V, Paljan D, Kansky A, Vujasinovic S. Prevalence of psoriasis in Croatia. Acta Derm Venereol Suppl (Stockh) 1989; 146: 178–179.
74. Brandrup F, Green A. The prevalence of psoriasis in Denmark. Acta Derm Venereol 1981; 61: 344–346.
75. Wolkenstein P, Revuz J, Roujeau JC et al. Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatol Basel Switz 2009; 218: 103–109.
76. Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol 2011; 165: 865–873.
77. Schaefer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatol Basel Switz 2008; 217: 169–172.
78. Naldi L, Colombo P, Placchesi EB et al. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology 2004; 208: 38–42.
79. Kavli G, Forde OH, Arnesen E, Stenvold SE. Psoriasis: familial predisposition and environmental factors. Br Med J 1985; 12: 999–1000.
80. Bø K, Thoresen M, Dalgard F. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. Dermatol Basel Switz 2008; 216: 40–45.
81. Olsen AO, Grjibovski A, Magnus P, Tambs K, Harris JR. Psoriasis in Norway as observed in a population-based Norwegian twin panel. Br J Dermatol 2005; 153: 346–351.
82. Lindberg M, Isacson D, Bingefors K. Self-reported skin diseases, quality of life and medication use: a nationwide pharmaco-epidemiological survey in Sweden. Acta Derm Venereol 2014; 94: 188–191.
83. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 2014; 70: 512–516.
84. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218–224.
85. Merola J, Li T, Qureshi A. Prevalence of psoriasis phenotypic subsets among US men and women. J Invest Dermatol 2014; 134(Suppl 1): S58–S58.
86. Gelfand JM, Stern RS, Nijsten T et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005; 52: 23–26.
87. Robinson D, Hackett M, Wong J et al. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr Med Res Opin 2006; 22: 989–1000.
88. Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009; 145: 379–382.
89. Eissing L, Rustenbach SJ, Krensel M et al. Psoriasis registries worldwide: systematic overview on registry publications. J Eur Acad Dermatol Venereol 2016; 30: 1000–1006.